Boswellin® Super is obtained from the gum exudate of Boswellia serrata trees commonly known as Frankincense.
| Salient features |
|---|
| 100% natural |
| No preservatives |
| No excipients |
| Established safety |
Efficacy of Boswellin® Super
Alleviates knee pain in rheumatoid arthritis
Boswellia serrata extract is a traditional remedy for joint health with an anti-inflammatory effect. The effect of Boswellin® Super on reducing knee pain was investigated in a randomized, double-blind, placebo-controlled trial. Patients with knee pain were assigned to receive either Boswellin® Super or placebo as one capsule daily for 8 weeks (Majeed et al., 2016).
Compared with baseline, the Boswellin® Super group patients showed significant improvements in the knee pain parameters such as Visual Analog Scale (VAS), Japanese Knee Osteoarthritis Measure (JKOM), and Western Ontario & Mc Master Universities Osteoarthritis Index (WOMAC) scores after 8 weeks of the intervention. The Boswellin® Super group patients also showed low serum hyaluronic acid levels than the placebo group (Majeed et al., 2016).
Measured values of JKOM total score, WOMAC total score and blood tests
| Item | Unit | Group | Week 0 | Week 4 | Week 8 |
|---|---|---|---|---|---|
| VAS | mm | Boswellin® Super | 68.8 (12.1) | 34.4 (23.8) | 35.6 (22.3) |
| Placebo | 71.8 (10.3) | 41.8 (24.2) | 39.6 (27.3) | ||
| JKOM total score | Point | Boswellin® Super | 48.3 (13.0) | 39.4 (11.0) | 38.8 (12.1) |
| Placebo | 48.5 (11.8) | 39.5 (8.2) | 36.4 (6.9) | ||
| WOMAC total score | Point | Boswellin® Super | 23.7 (16.7) | 14.3 (13.3) | 12.7 (14.2) |
| Placebo | 24.0 (15.9) | 14.6 (11.4) | 9.8 (8.8) | ||
| Hyaluronic acid | ng/mL | Boswellin® Super | 18.8 (14.3) | 15.9 (6.4) | 18.4 (8.9) |
| Placebo | 24.8 (24.8) | 50.3 (101.4) | 42.9 (66.8) | ||
| High sensitivity CRP | ng/mL | Boswellin® Super | 0.03 (0.03) | 0.05 (0.10) | 0.04 (0.05) |
| Placebo | 0.09 (0.14) | 0.04 (0.05) | 0.05 (0.07) |
Data expressed as Mean SD
Improve pain and joint function in non-rheumatic osteoarthritis condition
NILIN™ SR is a bilayered tablet formulation containing 272 mg Boswellin® (40% AKBBA) with 250 mg curcumin C3® complex (curcuminoids) and 100 mg gingerol (35%). In a 56 days study with 32 subjects (aged 40-65 years) who are having clinically diagnostic osteoarthritis of the knee, but no other rheumatologic conditions, showed a significant reduction in WOMAC scores in respect to all the three parameters; pain (P<0.0001), stiffness (P<0.0001) and physical disability (P<0.0001). Further, a significant reduction in the pain visual analogue score, improvement in 6-minute walk distance and HsCRP levels were also observed upon the supplementation with NILIN™ SR tablets (twice a day) (Natarajan and Majeed, 2012).
AKBA>KBA>ABA>BA
